Assessing the role of everolimus in reducing hepatocellular carcinoma recurrence after living donor liver transplantation for patients within the UCSF criteria: re-inventing the role of mammalian target of rapamycin inhibitors

BACKGROUNDS/AIMS: The protective effect of everolimus (EVR) in hepatocellular carcinoma (HCC) patients who receive liver transplantation in terms of reducing the recurrence has not been sufficiently investigated in clinical trials. In this second stage of our ongoing study, we intend to analyze the...

Full description

Saved in:
Bibliographic Details
Published in:Ann Hepatobiliary Pancreat Surg
Main Authors: Thorat, Ashok, Jeng, Long-Bin, Yang, Horng-Ren, Yeh, Chun-Chieh, Hsu, Shih-Chao, Chen, Te-Hung, Poon, Kin-Shing
Format: Artigo
Language:Inglês
Published: Korean Association of Hepato-Biliary-Pancreatic Surgery 2017
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5736740/
https://ncbi.nlm.nih.gov/pubmed/29264583
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14701/ahbps.2017.21.4.205
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items